Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 23, 2021, after the close
10-Q filed Aug 23, 2021, 54 days after period end · 0001171843-21-006102
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | — | $2.50K | $7.89K | $252.50K |
| Net Income | -$31.75M | -$1.85M | -$1.44M | -$627.05K |
| EPS Diluted | -$4.10 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.67 |
| -$1.45 |
| -$0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
